查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1404785

糖尿病足潰瘍治療的全球市場：規模、佔有率和趨勢分析報告 - 按治療方法、按潰瘍類型、按最終用途、按地區、細分市場預測，2024-2030 年

Diabetic Foot Ulcer Treatment Market Size, Share & Trends Analysis Report By Treatment (Biologics, Therapy Devices), By Ulcer Type (Ischemic, Neuropathic), By End-use (Hospitals, ASCs), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

糖尿病足潰瘍治療市場成長與趨勢：

預計2030年，全球糖尿病足潰瘍治療市場規模將達77.6億美元，2024年至2030年複合年成長率為6.0%。

糖尿病是該地區截肢、失明、中風、末期腎功能衰竭腎臟病、腎衰竭和心臟病的主要原因之一。根據國際糖尿病聯盟的數據，2017 年歐洲約有 6,600 萬人患有糖尿病。到 2045 年，這一數字預計將增至 8,100 萬。前 12 個月內與 DFU 相關的死亡率約為 5%，5 年後增加至 42%。

許多輔助性治療可以有效改善和治癒DFU，包括非手術清創劑、敷料、外用製劑、氧氣療法、負壓傷口護理、細胞生技藥品、人類生長因子、能量療法和全身性治療等。最近的研究表明，抑制有害的蛋白酶 MMP-9 酶可能會加速傷口癒合。亞洲地區久坐的生活方式、國內生產總值醫療保健支出不足、不健康的飲食習慣和報銷情況不佳是導致該地區糖尿病高成長的因素。因此，在亞洲地區觀察到了 DFU 的許多負面影響。

預計生技藥品領域將在 2023 年佔據最大的收益佔有率，並在預測期內呈現最高的成長率。生技藥品包括生長因子[如血管內皮生長因子（VEGF）和血小板衍生生長因子（PDGF）]、幹細胞和其他抗糖尿病藥物。這些藥物有助於降低高血糖，增加氧氣供應和循環，並修復失去的組織。因此，它擴大用於各個階段的傷口處理，被認為是 DFU 治療的理想選擇。 2021年創傷護理敷料佔據第二大銷售佔有率，其次是治療設備和抗生素製劑。

市場開拓公司不斷開發新的和改進的產品，以縮短 DFU 的癒合時間。 ConvaTec, Inc.、Acelity LP Inc.、3M Healthcare、Coloplast Corp. 和 Smith & Nephew Plc. 等公司在該市場處於領先地位。儘管爆發了 COVID-19，但這些公司報告稱，由於感染 COVID-19 的糖尿病患者併發症增加，對傷口處理產品的需求增加。據稱，隨著接受 COVID-19 治療的患者血糖水平升高導致糖尿病的發生，該市場預計將在 2021 年穩步成長。例如，2020 年在義大利，接受 COVID-19給藥的糖尿病患者整體比例在 5% 至 30% 之間。此外，Smith and Nephew 報告稱，他們新推出的創傷治療產品 PICO 7 的銷售將在 2020 年突破 100 萬件。因此，預計2020年市場將大幅成長，並在市場估計和預測期內保持穩定。

糖尿病足潰瘍治療市場報告亮點

  • 從治療方法來看，由於創傷治療時間縮短和血小板形成效率提高，生物製藥產業在 2023 年佔據了最大的銷售佔有率。
  • 按潰瘍類型分類，神經缺血性潰瘍細分市場在 2023 年佔據主要收益佔有率。
  • 由於治療採用率上升和經驗豐富的員工增加，醫院最終用途部門在 2023 年佔據第二大收益佔有率。
  • 由於市場參與者的存在以及治療成本和報銷方案的改善，北美在 2023 年獲得了最大的收益佔有率。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章 糖尿病足潰瘍治療市場的變數與趨勢

  • 市場體系展望
  • 市場動態
    • 市場促進因素影響分析
    • 市場抑制因素影響分析
  • 產業分析工具
    • 波特的分析
    • 宏觀經濟分析
  • COVID-19 影響分析
    • 疫情後市場洞察
  • 供應鏈分析

第4章糖尿病足潰瘍治療市場：治療方法分析

  • 治療方法變化分析/市場佔有率，2022-2030
  • 依治療方法
  • 市場規模/預測、趨勢分析，2018-2030
    • 創傷護理繃帶
    • 生技藥品
    • 治療設備
    • 抗生素藥物
    • 其他

第5章糖尿病足潰瘍治療市場：類型分析

  • 類型變化分析/市場佔有率，2022-2030
  • 按類型
  • 市場規模/預測、趨勢分析，2018-2030
    • 神經病變潰瘍
    • 缺血性潰瘍
    • 神經缺血性潰瘍

第6章糖尿病足潰瘍治療市場：最終用途分析

  • 最終用途變化分析/市場佔有率，2022-2030
  • 按最終用途
  • 市場規模/預測、趨勢分析，2018-2030
    • 醫院
    • 門診手術中心
    • 居家護理

第7章糖尿病足潰瘍治療市場：區域估計與趨勢分析

  • 糖尿病足潰瘍治療市場：區域展望
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 丹麥
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章競爭分析

  • 公司分類
  • 參與者概覽
  • 財務績效
  • 產品基準評效
  • 2023 年公司市場佔有率分析
  • 公司市場分析
  • 策略規劃
    • 併購
    • 新產品發布
    • 夥伴關係與協作
    • 擴張
    • 其他
  • 公司簡介
    • ConvaTec, Group Plc
    • Acelity LP, Inc.
    • 3M Health Care
    • Coloplast Corp.
    • Smith & Nephew Plc
    • B. Braun Melsungen AG
    • Medline Industries, LP.
    • Molnlycke Health Care AB
    • Medtronic Plc

第9章分析師的觀點

Product Code: GVR-2-68038-742-1

Diabetic Foot Ulcer Treatment Market Growth & Trends:

The global diabetic foot ulcer treatment market size is expected to reach USD 7.76 billion by 2030, registering a CAGR of 6.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. Diabetes is one of the major causes of amputation, blindness, stroke, end-stage renal failure, kidney failure, and heart attacks in this region. According to the International Diabetes Federation, ~66 million people were suffering from diabetes in Europe in 2017. The number is expected to increase to ~81 million by 2045. The mortality rate associated with DFU is ~5% in the first 12 months and increases up to 42% by the end of 5 years.

Many adjuvant therapies such as nonsurgical debridement agents, dressings and topical agents, oxygen therapies, negative pressure wound therapy, acellular bioproducts, human growth factors, energy-based therapies, and systemic therapies are said to effectively improve and cure DFU. Recent studies suggest that the inhibition of detrimental proteinase MMP-9 enzyme allows the body to heal the wound at a quicker rate. Sedentary lifestyle, poor GDP expenditure on healthcare, unhealthy food habits, and poor reimbursement scenarios in the Asian region are the factors responsible for the high growth of diabetes in this region. Hence, numerous ill effects of DFU are observed in the Asian region.

The biologics segment held the largest revenue share in 2023 and is expected to grow at the highest rate during the forecast period. Biologics include growth factors [such as Vascular Endothelial Growth Factor (VEGF) and Platelet-Derived Growth Factor (PDGF)], stem cells, and other anti-diabetic drugs. These agents help reduce hyperglycemia, increase oxygenation and circulation, and repair lost tissues. Therefore, they are increasingly being used for the management of wounds in different stages and are considered to be ideal for DFU treatment. Wound care dressings held the second-largest revenue share in 2021, followed by therapy devices and antibiotic medications.

Market players are constantly developing new and improved products to ensure quicker healing time for DFU. Companies like ConvaTec, Inc.; Acelity L.P. Inc.; 3M Healthcare; Coloplast Corp.; and Smith & Nephew Plc. are among the leaders in this market. Despite the COVID-19 outbreak, these players reported an increase in demand for their wound management products due to the increased complications of diabetic patients suffering from COVID-19 infection. The market was said to increase at a steady rate in 2021 as COVID-19 treated patients witnessed a rise in sugar levels leading to the onset of diabetes. For instance, the overall proportion of diabetic patients with COVID-19 ranged from 5% - 30% in Italy in 2020. Further, Smith and Nephew reported the sales of its newly launched wound healing product, PICO 7, to cross the 1 million mark in 2020. Hence, the market grew dramatically in 2020 and is estimated to stabilize during the forecast period.

Diabetic Foot Ulcer Treatment Market Report Highlights:

  • By treatment, the biologics segment captured the largest revenue share in 2023 owing to its reduced wound healing time and increased platelet formation efficiency
  • Based on ulcer type, the neuro-ischemic ulcers segment held the dominant revenue share in 2023
  • The hospitals end-use segment accounted for the second-largest revenue share in 2023 due to the increased adoption rate of treatment and highly experienced staff
  • North America grabbed the largest revenue share in 2023 due to the presence of market players and improved treatment cost and reimbursement scenario

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation
  • 1.2 Market Definition
  • 1.3 Research Methodology
  • 1.4 Information Procurement
    • 1.4.1 Purchased Database
    • 1.4.2 Gvr's Internal Database
    • 1.4.3 Secondary Sources
    • 1.4.4 Primary Research
  • 1.5 Information Or Data Analysis
    • 1.5.1 Data Analysis Models
  • 1.6 Market Formulation & Validation
  • 1.7 Model Details
    • 1.7.1 Commodity Flow Analysis
  • 1.8 List Of Secondary Sources
  • 1.9 List Of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3

Chapter 2 Executive Summary

  • 2.1 Market Snapshot (Regional)
  • 2.2 Segment Snapshot (Treatment And Type)
  • 2.3 Segment Snapshot (End-Use)
  • 2.4 Competitive Landscape

Chapter 3 Diabetic Foot Ulcer Treatment Market Variables And Trends

  • 3.1 Market Lineage Outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Impact Analysis
      • 3.2.1.1 Growing Prevalence Of Diabetes
      • 3.2.1.2 Rising Geriatric Population
      • 3.2.1.3 Increasing Government Initiative
    • 3.2.2 Market Restraint Impact Analysis
      • 3.2.2.1 High Cost Of Treatment
  • 3.3 Industry Analysis Tools
    • 3.3.1 Porter's Analysis
    • 3.3.2 Macroeconomic Analysis
  • 3.4 Covid-19 Impact Analysis
    • 3.4.1 Post-Pandemic Market Insights
  • 3.5 Supply Chain Analysis

Chapter 4 Diabetic Foot Ulcer Treatment Market: Treatment Analysis

  • 4.1 Treatment Movement Analysis & Market Share, 2022 & 2030
  • 4.2 Diabetic Foot Ulcer Treatment Market Estimates & Forecast, By Treatment (USD Million)
  • 4.3 Market Size & Forecasts And Trend Analysis, 2018 To 2030
    • 4.3.1 Wound Care Dressings
      • 4.3.1.1 Wound Care Dressings Market, 2018 - 2030 (USD Million)
      • 4.3.1.2 Alginate Dressings
      • 4.3.1.2.1 Alginate Dressings Market, 2018 - 2030 (USD Million)
      • 4.3.1.3 Hydrofiber Dressings
      • 4.3.1.3.1 Hydrofiber Dressings Market, 2018 - 2030 (USD Million)
      • 4.3.1.4 Foam Dressings
      • 4.3.1.4.1 Foam Dressings Market, 2018 - 2030 (USD Million)
      • 4.3.1.5 Film Dressing
      • 4.3.1.5.1 Film Dressing Market, 2018 - 2030 (USD Million)
      • 4.3.1.6 Hydrocolloid Dressings
      • 4.3.1.6.1 Hydrocolloid Dressings Market, 2018 - 2030 (USD Million)
      • 4.3.1.7 Surgical Dressings
      • 4.3.1.7.1 Surgical Dressings Market, 2018 - 2030 (USD Million)
      • 4.3.1.8 Hydrogel Dressings
      • 4.3.1.8.1 Hydrogel Dressings Market, 2018 - 2030 (USD Million)
    • 4.3.2 Biologics
      • 4.3.2.1 Biologics Market, 2018 - 2030 (USD Million)
      • 4.3.2.2 Growth Factors
      • 4.3.2.2.1 Growth Factors Market, 2018 - 2030 (USD Million)
      • 4.3.2.3 Skin Grafts
      • 4.3.2.3.1 Skin Grafts Market, 2018 - 2030 (USD Million)
    • 4.3.3 Therapy Devices
      • 4.3.3.1 Therapy Devices Market, 2018 - 2030 (USD Million)
      • 4.3.3.2 Negative Pressure Wound Therapy
      • 4.3.3.2.1 Negative Pressure Wound Therapy Market, 2018 - 2030 (USD Million)
      • 4.3.3.3 Ultrasound Therapy
      • 4.3.3.3.1 Ultrasound Therapy Market, 2018 - 2030 (USD Million)
    • 4.3.4 Antibiotic Medications
      • 4.3.4.1 Antibiotic Medications Market, 2018 - 2030 (USD Million)
    • 4.3.5 Others
      • 4.3.5.1 Others Market, 2018 - 2030 (USD Million)

Chapter 5 Diabetic Foot Ulcer Treatment Market: Type Analysis

  • 5.1 Type Movement Analysis & Market Share, 2022 & 2030
  • 5.2 Diabetic Foot Ulcer Treatment Market Estimates & Forecast, By Type (USD Million)
  • 5.3 Market Size & Forecasts And Trend Analysis, 2018 To 2030
    • 5.3.1 Neuropathic Ulcers
      • 5.3.1.1 Neuropathic Ulcers Market, 2018 - 2030 (USD Million)
    • 5.3.2 Ischemic Ulcers
      • 5.3.2.1 Ischemic Ulcers Market, 2018 - 2030 (USD Million)
    • 5.3.3 Neuro-Ischemic Ulcers
      • 5.3.3.1 Neuro-Ischemic Ulcers Market, 2018 - 2030 (USD Million)

Chapter 6 Diabetic Foot Ulcer Treatment Market: End-Use Analysis

  • 6.1 End-Use Movement Analysis & Market Share, 2022 & 2030
  • 6.2 Diabetic Foot Ulcer Treatment Market Estimates & Forecast, By End-Use (USD Million)
  • 6.3 Market Size & Forecasts And Trend Analysis, 2018 To 2030
    • 6.3.1 Hospitals
      • 6.3.1.1 Hospitals Market, 2018 - 2030 (USD Million)
    • 6.3.2 Ambulatory Surgical Centers
      • 6.3.2.1 Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
    • 6.3.3 Homecare
      • 6.3.3.1 Homecare Market, 2018 - 2030 (USD Million)

Chapter 7 Diabetic Foot Ulcer Treatment Market: Regional Estimates & Trend Analysis

  • 7.1 Diabetic Foot Ulcer Treatment Market: Regional Outlook
  • 7.2 North America
    • 7.2.1 North America Diabetic Foot Ulcer Treatment Market Estimates & Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 Key Country Dynamics
      • 7.2.2.2 Competitive Scenario
      • 7.2.2.3 Regulatory Framework
      • 7.2.2.4 Reimbursement Scenario
      • 7.2.2.5 U.S. Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3 Canada
      • 7.2.3.1 Key Country Dynamics
      • 7.2.3.2 Competitive Scenario
      • 7.2.3.3 Regulatory Framework
      • 7.2.3.4 Reimbursement Scenario
      • 7.2.3.5 Canada Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3 Europe
    • 7.3.1 Europe Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2 U.K
      • 7.3.2.1 Key Country Dynamics
      • 7.3.2.2 Competitive Scenario
      • 7.3.2.3 Regulatory Framework
      • 7.3.2.4 Reimbursement Scenario
      • 7.3.2.5 U.K Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3 Germany
      • 7.3.3.1 Key Country Dynamics
      • 7.3.3.2 Competitive Scenario
      • 7.3.3.3 Regulatory Framework
      • 7.3.3.4 Reimbursement Scenario
      • 7.3.3.5 Germany Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4 France
      • 7.3.4.1 Key Country Dynamics
      • 7.3.4.2 Competitive Scenario
      • 7.3.4.3 Regulatory Framework
      • 7.3.4.4 Reimbursement Scenario
      • 7.3.4.5 France Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5 Italy
      • 7.3.5.1 Key Country Dynamics
      • 7.3.5.2 Competitive Scenario
      • 7.3.5.3 Regulatory Framework
      • 7.3.5.4 Reimbursement Scenario
      • 7.3.5.5 Italy Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6 Spain
      • 7.3.6.1 Key Country Dynamics
      • 7.3.6.2 Competitive Scenario
      • 7.3.6.3 Regulatory Framework
      • 7.3.6.4 Reimbursement Scenario
      • 7.3.6.5 Spain Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7 Sweden
      • 7.3.7.1 Key Country Dynamics
      • 7.3.7.2 Competitive Scenario
      • 7.3.7.3 Regulatory Framework
      • 7.3.7.4 Reimbursement Scenario
      • 7.3.7.5 Sweden Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8 Denmark
      • 7.3.8.1 Key Country Dynamics
      • 7.3.8.2 Competitive Scenario
      • 7.3.8.3 Regulatory Framework
      • 7.3.8.4 Reimbursement Scenario
      • 7.3.8.5 Denmark Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9 Norway
      • 7.3.9.1 Key Country Dynamics
      • 7.3.9.2 Competitive Scenario
      • 7.3.9.3 Regulatory Framework
      • 7.3.9.4 Reimbursement Scenario
      • 7.3.9.5 Norway Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2 Japan
      • 7.4.2.1 Key Country Dynamics
      • 7.4.2.2 Competitive Scenario
      • 7.4.2.3 Regulatory Framework
      • 7.4.2.4 Reimbursement Scenario
      • 7.4.2.5 Japan Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3 China
      • 7.4.3.1 Key Country Dynamics
      • 7.4.3.2 Competitive Scenario
      • 7.4.3.3 Regulatory Framework
      • 7.4.3.4 Reimbursement Scenario
      • 7.4.3.5 China Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4 India
      • 7.4.4.1 Key Country Dynamics
      • 7.4.4.2 Competitive Scenario
      • 7.4.4.3 Regulatory Framework
      • 7.4.4.4 Reimbursement Scenario
      • 7.4.4.5 India Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5 Australia
      • 7.4.5.1 Key Country Dynamics
      • 7.4.5.2 Competitive Scenario
      • 7.4.5.3 Regulatory Framework
      • 7.4.5.4 Reimbursement Scenario
      • 7.4.5.5 Australia Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6 South Korea
      • 7.4.6.1 Key Country Dynamics
      • 7.4.6.2 Competitive Scenario
      • 7.4.6.3 Regulatory Framework
      • 7.4.6.4 Reimbursement Scenario
      • 7.4.6.5 South Korea Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7 Thailand
      • 7.4.7.1 Key Country Dynamics
      • 7.4.7.2 Competitive Scenario
      • 7.4.7.3 Regulatory Framework
      • 7.4.7.4 Reimbursement Scenario
      • 7.4.7.5 Thailand Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Latin America Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2 Brazil
      • 7.5.2.1 Key Country Dynamics
      • 7.5.2.2 Competitive Scenario
      • 7.5.2.3 Regulatory Framework
      • 7.5.2.4 Reimbursement Scenario
      • 7.5.2.5 Brazil Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3 Mexico
      • 7.5.3.1 Key Country Dynamics
      • 7.5.3.2 Competitive Scenario
      • 7.5.3.3 Regulatory Framework
      • 7.5.3.4 Reimbursement Scenario
      • 7.5.3.5 Mexico Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4 Argentina
      • 7.5.4.1 Key Country Dynamics
      • 7.5.4.2 Competitive Scenario
      • 7.5.4.3 Regulatory Framework
      • 7.5.4.4 Reimbursement Scenario
      • 7.5.4.5 Argentina Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6 Middle East & Africa
    • 7.6.1 Middle East & Africa Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2 South Africa
      • 7.6.2.1 Key Country Dynamics
      • 7.6.2.2 Competitive Scenario
      • 7.6.2.3 Regulatory Framework
      • 7.6.2.4 Reimbursement Scenario
      • 7.6.2.5 South Africa Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3 Saudi Arabia
      • 7.6.3.1 Key Country Dynamics
      • 7.6.3.2 Competitive Scenario
      • 7.6.3.3 Regulatory Framework
      • 7.6.3.4 Reimbursement Scenario
      • 7.6.3.5 Saudi Arabia Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4 UAE
      • 7.6.4.1 Key Country Dynamics
      • 7.6.4.2 Competitive Scenario
      • 7.6.4.3 Regulatory Framework
      • 7.6.4.4 Reimbursement Scenario
      • 7.6.4.5 UAE Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5 Kuwait
      • 7.6.5.1 Key Country Dynamics
      • 7.6.5.2 Competitive Scenario
      • 7.6.5.3 Regulatory Framework
      • 7.6.5.4 Reimbursement Scenario
      • 7.6.5.5 Kuwait Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8 Competitive Analysis

  • 8.1 Company Categorization
  • 8.2 Participants' Overview
  • 8.3 Financial Performance
  • 8.4 Product Benchmarking
  • 8.5 Company Market Share Analysis, 2023
  • 8.6 Company Market Position Analysis
  • 8.7 Strategy Mapping
    • 8.7.1 Mergers & Acquisitions
    • 8.7.2 New Product Launch
    • 8.7.3 Partnerships & Collaborations
    • 8.7.4 Expansion
    • 8.7.5 Others
  • 8.8 Company Profiles
    • 8.8.1 ConvaTec, Group Plc
      • 8.8.1.1 Company overview
      • 8.8.1.2 Finacial performance
      • 8.8.1.3 Product benchmarking
      • 8.8.1.4 Strategic initiatives
    • 8.8.2 Acelity L.P., Inc.
      • 8.8.2.1 Company overview
      • 8.8.2.2 Finacial performance
      • 8.8.2.3 Product benchmarking
      • 8.8.2.4 Strategic initiatives
    • 8.8.3 3M Health Care
      • 8.8.3.1 Company overview
      • 8.8.3.2 Finacial performance
      • 8.8.3.3 Product benchmarking
      • 8.8.3.4 Strategic initiatives
    • 8.8.4 Coloplast Corp.
      • 8.8.4.1 Company overview
      • 8.8.4.2 Finacial performance
      • 8.8.4.3 Product benchmarking
      • 8.8.4.4 Strategic initiatives
    • 8.8.5 Smith & Nephew Plc
      • 8.8.5.1 Company overview
      • 8.8.5.2 Finacial performance
      • 8.8.5.3 Product benchmarking
      • 8.8.5.4 Strategic initiatives
    • 8.8.6 B. Braun Melsungen AG
      • 8.8.6.1 Company overview
      • 8.8.6.2 Finacial performance
      • 8.8.6.3 Product benchmarking
      • 8.8.6.4 Strategic initiatives
    • 8.8.7 Medline Industries, LP.
      • 8.8.7.1 Company overview
      • 8.8.7.2 Finacial performance
      • 8.8.7.3 Product benchmarking
      • 8.8.7.4 Strategic initiatives
    • 8.8.8 Molnlycke Health Care AB
      • 8.8.8.1 Company overview
      • 8.8.8.2 Finacial performance
      • 8.8.8.3 Product benchmarking
      • 8.8.8.4 Strategic initiatives
    • 8.8.9 Medtronic Plc
      • 8.8.9.1 Company overview
      • 8.8.9.2 Finacial performance
      • 8.8.9.3 Product benchmarking
      • 8.8.9.4 Strategic initiatives

Chapter 9 Analyst Perspective

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. North America diabetic foot ulcer market, By country, 2018 - 2030 (USD Million)
  • Table 4. North America diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 5. North America diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 6. North America diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 7. U.S. diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 8. U.S. diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 9. U.S. diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 10. Canada diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 11. Canada diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 12. Canada diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 13. Europe diabetic foot ulcer market, By country, 2018 - 2030 (USD Million)
  • Table 14. Europe diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 15. Europe diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 16. Europe diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 17. UK diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 18. UK diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 19. UK diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 20. Germany diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 21. Germany diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 22. Germany diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 23. France diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 24. France diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 25. France diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 26. Italy diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 27. Italy diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 28. Italy diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 29. Denmark diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 30. Denmark diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 31. Denmark diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 32. Sweden diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 33. Sweden diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 34. Sweden diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 35. Norway diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 36. Norway diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 37. Norway diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 38. Asia Pacific diabetic foot ulcer market, By country, 2018 - 2030 (USD Million)
  • Table 39. Asia Pacific diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 40. Asia Pacific diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 41. Asia Pacific diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 42. Japan diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 43. Japan diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 44. Japan diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 45. China diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 46. China diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 47. China diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 48. India diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 49. India diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 50. India diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 51. Australia diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 52. Australia diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 53. Australia diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 54. South Korea diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 55. South Korea diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 56. South Korea diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 57. Thailand diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 58. Thailand diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 59. Thailand diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 60. Latin America diabetic foot ulcer market, By Country, 2018 - 2030 (USD Million)
  • Table 61. Latin America diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 62. Latin America diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 63. Latin America diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 64. Brazil diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 65. Brazil diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 66. Brazil diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 67. Mexico diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 68. Mexico diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 69. Mexico diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 70. Argentina diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 71. Argentina diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 72. Argentina diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 73. Middle East & Africa diabetic foot ulcer market, By country, 2018 - 2030 (USD Million)
  • Table 74. Middle East & Africa diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 75. Middle East & Africa diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 76. Middle East & Africa diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 77. South Africa diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 78. South Africa diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 79. South Africa diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 80. Saudi Arabia diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 81. Saudi Arabia diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 82. Saudi Arabia diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 83. UAE diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 84. UAE diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 85. UAE diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)
  • Table 86. Kuwait diabetic foot ulcer market, By treatment, 2018 - 2030 (USD Million)
  • Table 87. Kuwait diabetic foot ulcer market, By ulcer type, 2018 - 2030 (USD Million)
  • Table 88. Kuwait diabetic foot ulcer market, By end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Diabetic foot ulcer treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot (Treatment & type)
  • Fig. 11 Segment snapshot (End-use)
  • Fig. 12 Competitive landscape
  • Fig. 13 Wound care market value, 2023 (USD Billion)
  • Fig. 14 Diabetic foot ulcer treatment market dynamics
  • Fig. 15 Number of deaths before the age of 60 due to diabetes worldwide in 2021, by Region (in thousands)
  • Fig. 16 Projections of older adult population in the U.S.: 2020 to 2060
  • Fig. 17 Diabetic foot ulcer treatment market: PORTER's analysis
  • Fig. 18 Diabetic foot ulcer treatment market: PESTEL analysis
  • Fig. 19 Diabetic foot ulcer treatment market: by treatment: Key takeaways
  • Fig. 20 Diabetic foot ulcer treatment market, by treatment: Market share, 2023 & 2030
  • Fig. 21 Wound care dressings market, 2018 - 2030 (USD Million)
  • Fig. 22 Alginate dressings market, 2018 - 2030 (USD Million)
  • Fig. 23 Hydrofiber dressings market, 2018 - 2030 (USD Million)
  • Fig. 24 Foam dressings market, 2018 - 2030 (USD Million)
  • Fig. 25 Film dressing market, 2018 - 2030 (USD Million)
  • Fig. 26 Hydrocolloid dressings market, 2018 - 2030 (USD Million)
  • Fig. 27 Surgical dressings market, 2018 - 2030 (USD Million)
  • Fig. 28 Hydrogel dressings market, 2018 - 2030 (USD Million)
  • Fig. 29 Biologics market, 2018 - 2030 (USD Million)
  • Fig. 30 Growth factors market, 2018 - 2030 (USD Million)
  • Fig. 31 Skin grafts market, 2018 - 2030 (USD Million)
  • Fig. 32 Therapy devices market, 2018 - 2030 (USD Million)
  • Fig. 33 Negative pressure wound therapy market, 2018 - 2030 (USD Million)
  • Fig. 34 Ultrasound therapy market, 2018 - 2030 (USD Million)
  • Fig. 35 Antibiotic medications market, 2018 - 2030 (USD Million)
  • Fig. 36 Others market, 2018 - 2030 (USD Million)
  • Fig. 37 Diabetic foot ulcer treatment market: by type: Key takeaways
  • Fig. 38 Diabetic foot ulcer treatment market, by type: Market share, 2023 & 2030
  • Fig. 39 Neuropathic ulcers market, 2018 - 2030 (USD Million)
  • Fig. 40 Ischemic ulcers market, 2018 - 2030 (USD Million)
  • Fig. 41 Neuro-ischemic ulcers market, 2018 - 2030 (USD Million)
  • Fig. 42 Diabetic foot ulcer treatment market: by end-use: Key takeaways
  • Fig. 43 Diabetic foot ulcer treatment market, by end-use: Market share, 2023 & 2030
  • Fig. 44 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 45 Ambulatory surgical centers market, 2018 - 2030 (USD Million)
  • Fig. 46 Homecare market, 2018 - 2030 (USD Million)
  • Fig. 47 Diabetic foot ulcer treatment market revenue, by region, 2023 & 2030 (USD Million)
  • Fig. 48 Regional marketplace: Key takeaways
  • Fig. 49 Regional marketplace: Key takeaways
  • Fig. 50 North America diabetic foot ulcer treatment market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Reimbursement scenario
  • Fig. 53 U.S. diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Canada diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Europe diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 UK diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Germany diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 France diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Italy diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Spain diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Sweden diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Denmark diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Norway diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Asia Pacific diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Reimbursement procurement process
  • Fig. 76 Japan diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 China diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 India diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Australia diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 South Korea diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Thailand diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Latin America diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Brazil diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Mexico diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Argentina diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Middle East & Africa diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 South Africa diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 Saudi Arabia diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 UAE diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Key country dynamics
  • Fig. 102 Kuwait diabetic foot ulcer treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 103 Key company categorization
  • Fig. 104 Company market share analysis, 2023
  • Fig. 105 Company market position analysis
  • Fig. 106 Strategy mapping